Benign melanocytic nevi harbour trunk nucleotide changes, such as BRAF and NRAS mutations, before progressing to melanoma and accumulate nucleotide changes in TERT promoter at the transition from benign nevus to melanoma in situ (Damsky and Bosenberg, 2017; Colebatch et al., 2022). This evidence concerns the gene BRAF and melanoma.